div
Latest News For Cancer / Oncology
Bristol-Myers Squibb And PDL BioPharma Enter Global Alliance To Develop Novel Treatment For Multiple Myeloma
21 Aug 2008
Researcher Aims To 'Unmask' Cancer Cells To Trigger Body's Immune System
21 Aug 2008
New Insights Into The Regulation Of PTEN Tumor Suppressor Function
21 Aug 2008
View more news...
Latest Videos for Cancer
Monitoring and Adherence in CML
Imatinib, or Gleevec, is a targeted anticancer drug that can hold on chronic myelogenous leukemia (CML) in check for most patients for many age. It is important for patients to take imatinib as official by their doctor to fight the disease and to guard against
